Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates
about
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugatesSynthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in miceEpitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgGRole of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharideMeningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse modelCurrent status of meningococcal group B vaccine candidates: capsular or noncapsular?Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin.Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.
P2860
Q28333277-78BC2357-6DB7-4FF7-9906-43292F8E09AEQ28346515-9AE97DF0-0B60-48A9-B41C-E6E1E1B59FAEQ28367535-94B9C422-0E75-4D04-B0B9-EE79C8E08DF7Q34111798-646CE811-84A5-4EC2-920B-1BF1F3A98BF6Q34521522-185388CD-DAAF-4061-AAF4-B7ED85EA3B1DQ34529116-4B8C7A24-3F79-4168-ABFD-2138309C336BQ36003444-57C039BD-FD1B-4725-ABF1-785E87268615Q36642138-F66F2378-7EAC-4FDE-B7DC-C4E447EF89DFQ36898518-BAE76644-FE00-4822-95F5-AB9A63DDA37FQ36950294-7FDDB3BD-F0B1-4AA9-8905-000B27F04EC6Q36967322-54EDCC67-897C-4BFD-BAFA-787C022BE816Q36975393-18B8F59B-190D-451E-8389-D14917A9DFD1Q37058833-A177BBD9-567A-47DF-AFE4-0E638B888520Q40056277-317A79F9-6891-4593-BDD2-EF0B20F03565Q42415387-ADFC7661-A5A4-4416-8555-53D85AD079BE
P2860
Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Modulation of the immune respo ...... e properties of the conjugates
@ast
Modulation of the immune respo ...... e properties of the conjugates
@en
type
label
Modulation of the immune respo ...... e properties of the conjugates
@ast
Modulation of the immune respo ...... e properties of the conjugates
@en
prefLabel
Modulation of the immune respo ...... e properties of the conjugates
@ast
Modulation of the immune respo ...... e properties of the conjugates
@en
P2093
P2860
P1476
Modulation of the immune respo ...... e properties of the conjugates
@en
P2093
De Reuver MJ
Verheul AF
Versteeg AA
P2860
P304
P407
P577
1989-04-01T00:00:00Z